$14.20
0.503.65%
Pre-Market: 7:00 AM EDT
Capricor Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Capricor Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.38 | $-0.36 | -5.56 % |
Q2 | 2024-08-07 | $-0.35 | $-0.36 | 2.78 % |
Q1 | 2024-05-13 | $-0.31 | $-0.11 | -181.8 % |
Q4 | 2024-02-29 | $-0.02 | $-0.09 | 77.8 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $2.26M | $3.57M | -36.6 % |
Q2 | 2024-08-07 | $3.97M | $3.66M | 8.50 % |
Q1 | 2024-05-13 | $4.91M | $9.70M | -49.4 % |
Q4 | 2024-02-29 | $12.09M | $10.60M | 14.0 % |
Capricor Therapeutics (CAPR) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.38, which missed the estimate of $-0.36.
The Actual Revenue was $2.3M, which missed the estimate of $3.6M.
Browse earnings estimates, EPS, and revenue on all stocks.